Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
-94.32%
Change (1 year)
Categories
Acorda Therapeutics (ACOR) Fails to deliver data
Key failure to deliver metrics for Acorda Therapeutics :
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $0.01 M
Failures to deliver for Acorda Therapeutics (ACOR) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Acorda Therapeutics (ACOR) - since 2021
Volume in USD (price x number of shares), data since 2021Acorda Therapeutics (ACOR) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $0.16 M | -91.31% |
| 2022 | $1.95 M | -87.5% |
| 2021 | $15.62 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $3.07 M | $35.88 M | 🇺🇸 USA |
 Repligen
RGEN | $17.03 M | $0.11 B | 🇺🇸 USA |
 Affimed
AFMD | $0 M | $0.73 M | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $0.8 M | $7.12 M | 🇺🇸 USA |